Active: Biomed Pharmacother Clear all

GWAS 2022-02-21

Whole-exome sequencing reveals genetic variations in humans with differential sensitivity to sevoflurane：A prospective observational study.

Wei Y, Zhang D et al.

Biomed Pharmacother

The anesthesia sensitivity is heterogeneous both in animals and humans, while the underlying molecul...

End-tidal sevoflurane concentration

500

Participants

N/A

Studies

Details PubMed

GWAS 2022-02-08

A pharmacogenomic investigation of the cardiac safety profile of ondansetron in children and pregnant women.

Drögemöller BI, Wright GEB et al.

Biomed Pharmacother

Ondansetron is a highly effective antiemetic for the treatment of nausea and vomiting. However, this...

Response to ondansetron (change in QTc)

257

Participants

N/A

Studies

Details PubMed

GWAS 2021-09-22

Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment.

Lin JJ, Loucks CM et al.

Biomed Pharmacother

The current use of ribavirin in difficult-to-cure chronic hepatitis C patients (HCV) and patients wi...

Ribavirin-induced anemia in chronic hepatitis C

188

Participants

N/A

Studies

Details PubMed

Title

Author

Journal

Disease/Trait

Date

Actions

Whole-exome sequencing reveals genetic variations in humans with differential sensitivity to sevoflurane：A prospective observational study.

Wei Y, Zhang D et al.

Biomed Pharmacother

End-tidal sevoflurane concentration

2022-02-21

A pharmacogenomic investigation of the cardiac safety profile of ondansetron in children and pregnant women.

Drögemöller BI, Wright GEB et al.

Biomed Pharmacother

Response to ondansetron (change in QTc)

2022-02-08

Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment.

Lin JJ, Loucks CM et al.

Biomed Pharmacother

Ribavirin-induced anemia in chronic hepatitis C

2021-09-22